SLP
Simulations Plus, Inc.
Medical - Healthcare Information Services
Market Cap$324M
5Y Perf.-68.3%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SLP vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1712.35T
5Y Perf.-58.8%
SLP vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SLP | DBVT |
|---|---|---|
| Industry | Medical - Healthcare Information Services | Biotechnology |
| Market Cap | $324M | $1712.35T |
| Revenue (TTM) | $79M | $0.00 |
| Net Income (TTM) | $-64M | $-168M |
| Gross Margin | 59.6% | — |
| Operating Margin | -89.2% | — |
| Forward P/E | 18.0x | — |
| Total Debt | $616K | $22M |
| Cash & Equiv. | $31M | $194M |
SLP vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SLP
DBVT
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Simulations Plus, I… (SLP) | 100 | 31.7 | -68.3% |
| DBV Technologies S.… (DBVT) | 100 | 41.2 | -58.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SLP vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: SLP leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. DBV Technologies S.A. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
SLP
Simulations Plus, Inc.
The Income Pick
SLP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 4 yrs, beta 1.25
- Rev growth 13.1%, EPS growth -7.6%, 3Y rev CAGR 13.7%
- 104.0% 10Y total return vs DBVT's -87.0%
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Quality Compounder
DBVT is the clearest fit if your priority is quality and momentum.
- 0.3% margin vs SLP's -81.7%
- +110.4% vs SLP's -44.6%
Best for: quality and momentum
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | SLP | 13.1% revenue growth vs DBVT's -100.0% |
| Quality / Margins | DBVT | 0.3% margin vs SLP's -81.7% |
| Stability / Safety | SLP | Beta 1.25 vs DBVT's 1.26, lower leverage |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | DBVT | +110.4% vs SLP's -44.6% |
| Efficiency (ROA) | SLP | -46.6% ROA vs DBVT's -89.0% |
SLP vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
SLP vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLSLPLAGGINGDBVT
DBVTDBV Technologies S.A.
1leads
SLPSimulations Plus, Inc.
3leads
6 Total Categories
CATEGORYLEADERvs DBVTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
SLP1/1
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
SLP6/7
Total Returns1Y, 3Y, 5Y total returns with dividends
DBVT5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
SLP1/1
Income & Cash Flow (Last 12 Months)
SLP leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
SLP and DBVT operate at a comparable scale, with $79M and $0 in trailing revenue.
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $79M | $0 |
| EBITDAEarnings before interest/tax | -$63M | -$112M |
| Net IncomeAfter-tax profit | -$64M | -$168M |
| Free Cash FlowCash after capex | $23M | -$151M |
| Gross MarginGross profit ÷ Revenue | +59.6% | — |
| Operating MarginEBIT ÷ Revenue | -89.2% | — |
| Net MarginNet income ÷ Revenue | -81.7% | — |
| FCF MarginFCF ÷ Revenue | +29.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +91.5% |
SLP leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
Evenly matched — SLP and DBVT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $324M | $1712.35T |
| Enterprise ValueMkt cap + debt − cash | $293M | $1712.35T |
| Trailing P/EPrice ÷ TTM EPS | -4.99x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.01x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 4.09x | — |
| Price / BookPrice ÷ Book value/share | 2.59x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 18.58x | — |
Evenly matched — SLP and DBVT each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
SLP leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
SLP delivers a -50.5% return on equity — every $100 of shareholder capital generates $-51 in annual profit, vs $-130 for DBVT. SLP carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), SLP scores 6/9 vs DBVT's 4/9, reflecting solid financial health.
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | -50.5% | -130.2% |
| ROA (TTM)Return on assets | -46.6% | -89.0% |
| ROICReturn on invested capital | -39.6% | — |
| ROCEReturn on capital employed | -44.1% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 0.13x |
| Net DebtTotal debt minus cash | -$30M | -$172M |
| Cash & Equiv.Liquid assets | $31M | $194M |
| Total DebtShort + long-term debt | $616,000 | $22M |
| Interest CoverageEBIT ÷ Interest expense | — | -189.82x |
SLP leads this category, winning 6 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBVT five years ago would be worth $3,090 today (with dividends reinvested), compared to $2,950 for SLP. Over the past 12 months, DBVT leads with a +110.4% total return vs SLP's -44.6%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs SLP's -26.0% — a key indicator of consistent wealth creation.
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | -11.3% | +4.9% |
| 1-Year ReturnPast 12 months | -44.6% | +110.4% |
| 3-Year ReturnCumulative with dividends | -59.6% | +19.7% |
| 5-Year ReturnCumulative with dividends | -70.5% | -69.1% |
| 10-Year ReturnCumulative with dividends | +104.0% | -87.0% |
| CAGR (3Y)Annualised 3-year return | -26.0% | +6.2% |
DBVT leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — SLP and DBVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
SLP is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 76.3% from its 52-week high vs SLP's 47.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.25x | 1.26x |
| 52-Week HighHighest price in past year | $34.01 | $26.18 |
| 52-Week LowLowest price in past year | $11.09 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +47.2% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 67.9 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 315K | 252K |
Evenly matched — SLP and DBVT each lead in 1 of 2 comparable metrics.
Analyst Outlook
SLP leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates SLP as "Buy" and DBVT as "Buy". Consensus price targets imply 248.7% upside for SLP (target: $56) vs 131.8% for DBVT (target: $46).
| Metric | SLPSimulations Plus,… | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $56.00 | $46.33 |
| # AnalystsCovering analysts | 8 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 4 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SLP leads this category, winning 1 of 1 comparable metric.
Key Takeaway
SLP leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DBVT leads in 1 (Total Returns). 2 tied.
Best OverallSimulations Plus, Inc. (SLP)Leads 3 of 6 categories
Loading custom metrics...
SLP vs DBVT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SLP or DBVT a better buy right now?
Analysts rate Simulations Plus, Inc.
(SLP) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SLP or DBVT?
Over the past 5 years, DBV Technologies S.
A. (DBVT) delivered a total return of -69. 1%, compared to -70. 5% for Simulations Plus, Inc. (SLP). Over 10 years, the gap is even starker: SLP returned +104. 0% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SLP or DBVT?
By beta (market sensitivity over 5 years), Simulations Plus, Inc.
(SLP) is the lower-risk stock at 1. 25β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 1% more volatile than SLP relative to the S&P 500. On balance sheet safety, Simulations Plus, Inc. (SLP) carries a lower debt/equity ratio of 0% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — SLP or DBVT?
On earnings-per-share growth, the picture is similar: DBV Technologies S.
A. grew EPS -347. 5% year-over-year, compared to -757. 1% for Simulations Plus, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SLP or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -81. 7% for Simulations Plus, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -89. 3% for SLP. At the gross margin level — before operating expenses — SLP leads at 58. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SLP or DBVT more undervalued right now?
Analyst consensus price targets imply the most upside for SLP: 248.
7% to $56. 00.
07Which pays a better dividend — SLP or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is SLP or DBVT better for a retirement portfolio?
For long-horizon retirement investors, Simulations Plus, Inc.
(SLP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 25), +104. 0% 10Y return). Both have compounded well over 10 years (SLP: +104. 0%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SLP and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.